Skip to content
lifestyle.goodsciencing.com
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
Relmada Therapeutics
Relmada Therapeutics Appoints Uro-Oncology Leader Bipin Dalmia as Chief Business Officer
July 28, 2026
Relmada Therapeutics to Report Second Quarter 2026 Financial Results on Thursday, August 6, 2026
July 16, 2026
Relmada Therapeutics Joins Russell 2000® and Russell 3000® Indexes
June 29, 2026
Relmada Therapeutics Appoints CNS Drug Development Veteran Michael Quirk as Senior Advisor for Sepranolone Program
June 11, 2026
Relmada Therapeutics Reports First Quarter 2026 Financial Results and Provides Business Update
May 13, 2026
Relmada Therapeutics to Report First Quarter 2026 Financial Results on Tuesday, May 12, 2026
May 7, 2026
Relmada Therapeutics to Present NDV-01 Abstracts at AUA2026
May 5, 2026
Relmada Therapeutics Reports Fourth Quarter and Full Year 2025 Results and Provides Business Update
March 19, 2026
Relmada Therapeutics to Report Fourth Quarter 2025 Financial Results on Thursday, March 19, 2026
March 12, 2026
Relmada Therapeutics to Present at the Leerink Partners Global Healthcare Conference
March 9, 2026
1
2
Next Page
→